Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease.
Jalink JM, Jacobs CFJ Dr, Khwaja JK, Evers DE, Bruggeman CB, Fattizzo BF, Michel MM, Crickx EC, Hill QAH, Jaeger UJ, Kater APK, Mäkelburg ABUM, Breedijk AB, Te Boekhorst PAW, Hoeks MPAH, de Haas MdH, D'Sa SPD, Vos JMI. Jalink JM, et al. Among authors: jaeger uj. Blood Adv. 2024 Mar 20:bloodadvances.2024012585. doi: 10.1182/bloodadvances.2024012585. Online ahead of print. Blood Adv. 2024. PMID: 38507742
Narcissistic dimensions and depressive symptoms in patients across mental disorders in cognitive behavioural therapy and in psychoanalytic interactional therapy in Germany: a prospective cohort study.
Richter M, Mota S, Hater L, Bratek R, Goltermann J, Barkhau C, Gruber M, Repple J, Storck M, Blitz R, Grotegerd D, Masuhr O, Jaeger U, Baune BT, Dugas M, Walter M, Dannlowski U, Buhlmann U, Back M, Opel N. Richter M, et al. Among authors: jaeger u. Lancet Psychiatry. 2023 Dec;10(12):955-965. doi: 10.1016/S2215-0366(23)00293-6. Epub 2023 Oct 13. Lancet Psychiatry. 2023. PMID: 37844592
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study.
Olszewski AJ, Phillips TJ, Hoffmann MS, Armand P, Kim TM, Yoon DH, Mehta A, Greil R, Westin J, Lossos IS, Munoz JL, Sit J, Wei MC, Yang A, Chen V, Purev E, Yee DL, Jaeger U. Olszewski AJ, et al. Among authors: jaeger u. Blood Adv. 2023 Oct 24;7(20):6055-6065. doi: 10.1182/bloodadvances.2023010840. Blood Adv. 2023. PMID: 37581593 Free PMC article. Clinical Trial.
Photovoltaics at multi-terawatt scale: Waiting is not an option.
Haegel NM, Verlinden P, Victoria M, Altermatt P, Atwater H, Barnes T, Breyer C, Case C, De Wolf S, Deline C, Dharmrin M, Dimmler B, Gloeckler M, Goldschmidt JC, Hallam B, Haussener S, Holder B, Jaeger U, Jaeger-Waldau A, Kaizuka I, Kikusato H, Kroposki B, Kurtz S, Matsubara K, Nowak S, Ogimoto K, Peter C, Peters IM, Philipps S, Powalla M, Rau U, Reindl T, Roumpani M, Sakurai K, Schorn C, Schossig P, Schlatmann R, Sinton R, Slaoui A, Smith BL, Schneidewind P, Stanbery BJ, Topic M, Tumas W, Vasi J, Vetter M, Weber E, Weeber AW, Weidlich A, Weiss D, Bett AW. Haegel NM, et al. Among authors: jaeger u. Science. 2023 Apr 7;380(6640):39-42. doi: 10.1126/science.adf6957. Epub 2023 Apr 6. Science. 2023. PMID: 37023188
Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma.
Jaeger U, Tam CS, Borchmann P, McGuirk JP, Johansen M, Waller EK, Jaglowski S, Andreadis C, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Salles G, Schuster SJ, He F, Maziarz RT, Mayer S, Makita S, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P, Goto H, Colicino S, Agarwal A, Lobetti-Bodoni C, Bishop MR. Jaeger U, et al. Blood Adv. 2022 Aug 23;6(16):4816-4820. doi: 10.1182/bloodadvances.2021006193. Blood Adv. 2022. PMID: 35687492 Free PMC article. No abstract available.
Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab.
Seymour JF, Kipps TJ, Eichhorst BF, D'Rozario J, Owen CJ, Assouline S, Lamanna N, Robak T, de la Serna J, Jaeger U, Cartron G, Montillo M, Mellink C, Chyla B, Panchal A, Lu T, Wu JQ, Jiang Y, Lefebure M, Boyer M, Kater AP. Seymour JF, et al. Among authors: jaeger u. Blood. 2022 Aug 25;140(8):839-850. doi: 10.1182/blood.2021015014. Blood. 2022. PMID: 35605176 Free PMC article. Clinical Trial.
240 results